Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation March 7, 2016 Our paper “Mutant Calreticulin Requires Both its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation” gets published in Cancer Discovery! Related Posts Frederike is awarded a fellowship fund from the DFG Dr. Shannon Elf presents a Late Breaking Abstract at the Annual ASH Conference Ann Mullally receives Clinical Investigator Continuation Grant